Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000878088-14-000014
Filing Date
2014-05-15
Accepted
2014-05-14 20:54:56
Documents
13
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q prx-20140331x10q.htm 10-Q 1868402
2 AMENDED PLAN prx-2014331xex101.htm EX-10.1 74884
3 FORM OF AGREEMENT prx-2014331xex102.htm EX-10.2 95079
4 CERT prx-2014331xex311.htm EX-31.1 13305
5 CERT prx-2014331xex312.htm EX-31.2 13289
6 CEO CERT prx-2014331xex321.htm EX-32.1 6016
7 CFO CERT prx-2014331xex322.htm EX-32.2 5610
  Complete submission text file 0000878088-14-000014.txt   14659322

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT prx-20140331.xml EX-101.INS 2612101
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prx-20140331.xsd EX-101.SCH 83795
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prx-20140331_cal.xml EX-101.CAL 121506
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prx-20140331_def.xml EX-101.DEF 479177
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prx-20140331_lab.xml EX-101.LAB 952896
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prx-20140331_pre.xml EX-101.PRE 634693
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 201-802-4000
PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)

EIN.: 223122182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10827 | Film No.: 14843440
SIC: 2834 Pharmaceutical Preparations